• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习指导的药物不良反应与体外基于靶点的药理学关联。

Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology.

机构信息

Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, United States.

The Jackson Laboratory, Farmington, CT 06032, United States.

出版信息

EBioMedicine. 2020 Jul;57:102837. doi: 10.1016/j.ebiom.2020.102837. Epub 2020 Jun 18.

DOI:10.1016/j.ebiom.2020.102837
PMID:32565027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7379147/
Abstract

BACKGROUND

Adverse drug reactions (ADRs) are one of the leading causes of morbidity and mortality in health care. Understanding which drug targets are linked to ADRs can lead to the development of safer medicines.

METHODS

Here, we analyse in vitro secondary pharmacology of common (off) targets for 2134 marketed drugs. To associate these drugs with human ADRs, we utilized FDA Adverse Event Reports and developed random forest models that predict ADR occurrences from in vitro pharmacological profiles.

FINDINGS

By evaluating Gini importance scores of model features, we identify 221 target-ADR associations, which co-occur in PubMed abstracts to a greater extent than expected by chance. Amongst these are established relations, such as the association of in vitro hERG binding with cardiac arrhythmias, which further validate our machine learning approach. Evidence on bile acid metabolism supports our identification of associations between the Bile Salt Export Pump and renal, thyroid, lipid metabolism, respiratory tract and central nervous system disorders. Unexpectedly, our model suggests PDE3 is associated with 40 ADRs.

INTERPRETATION

These associations provide a comprehensive resource to support drug development and human biology studies.

FUNDING

This study was not supported by any formal funding bodies.

摘要

背景

药物不良反应(ADR)是医疗保健中发病率和死亡率的主要原因之一。了解哪些药物靶点与 ADR 相关,可有助于开发更安全的药物。

方法

在这里,我们分析了 2134 种市售药物常见(非)靶标的体外二次药理学。为了将这些药物与人类 ADR 相关联,我们利用了 FDA 不良事件报告,并开发了随机森林模型,可根据体外药理学特征预测 ADR 的发生。

发现

通过评估模型特征的基尼重要性得分,我们确定了 221 个靶标-ADR 关联,这些关联在 PubMed 摘要中比随机出现的可能性更大。其中包括已建立的关系,例如体外 hERG 结合与心律失常的关联,这进一步验证了我们的机器学习方法。关于胆汁酸代谢的证据支持我们鉴定出胆汁盐输出泵与肾脏、甲状腺、脂质代谢、呼吸道和中枢神经系统疾病之间的关联。出乎意料的是,我们的模型表明 PDE3 与 40 种 ADR 相关。

解释

这些关联为支持药物开发和人类生物学研究提供了全面的资源。

资金

本研究没有得到任何正式资助机构的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/1b72496bc5d8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/0242282e0003/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/6dd0cd93d73b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/7121378072fd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/1b72496bc5d8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/0242282e0003/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/6dd0cd93d73b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/7121378072fd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3d6/7379147/1b72496bc5d8/gr4.jpg

相似文献

1
Machine learning guided association of adverse drug reactions with in vitro target-based pharmacology.机器学习指导的药物不良反应与体外基于靶点的药理学关联。
EBioMedicine. 2020 Jul;57:102837. doi: 10.1016/j.ebiom.2020.102837. Epub 2020 Jun 18.
2
Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data.利用 FAERS 数据中的人口统计学和非临床药物特征预测药物不良反应。
Sci Rep. 2024 Oct 9;14(1):23636. doi: 10.1038/s41598-024-74505-2.
3
Supervised signal detection for adverse drug reactions in medication dispensing data.基于配药数据的药物不良反应的有监督信号检测。
Comput Methods Programs Biomed. 2018 Jul;161:25-38. doi: 10.1016/j.cmpb.2018.03.021. Epub 2018 Apr 14.
4
Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learning.改变检测罕见药物不良反应的范式:从传统的不成比例分析,到新的机器学习方法。
Expert Opin Drug Saf. 2022 Oct;21(10):1235-1238. doi: 10.1080/14740338.2022.2131770. Epub 2022 Oct 4.
5
Monitoring drug safety in Astrakhan, Russia.俄罗斯阿斯特拉罕地区的药物安全监测。
Int J Risk Saf Med. 2015;27 Suppl 1:S33-4. doi: 10.3233/JRS-150680.
6
Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study.从药品说明书中提取药物不良反应的本体组织和生物信息学分析:开发和可用性研究。
J Med Internet Res. 2020 Jul 20;22(7):e20443. doi: 10.2196/20443.
7
Computational models for the prediction of adverse cardiovascular drug reactions.用于预测不良心血管药物反应的计算模型。
J Transl Med. 2019 May 22;17(1):171. doi: 10.1186/s12967-019-1918-z.
8
A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.一项临床前的二级药物药理学资源阐明了已上市药物的靶标不良药物反应关联。
Nat Commun. 2023 Jul 19;14(1):4323. doi: 10.1038/s41467-023-40064-9.
9
Pharmacogenomics of off-target adverse drug reactions.药物基因组学与非靶标不良反应
Br J Clin Pharmacol. 2017 Sep;83(9):1896-1911. doi: 10.1111/bcp.13294. Epub 2017 Apr 27.
10
Broad-Spectrum Profiling of Drug Safety via Learning Complex Network.通过学习复杂网络进行药物安全的广谱分析
Clin Pharmacol Ther. 2020 Jun;107(6):1373-1382. doi: 10.1002/cpt.1750. Epub 2020 Feb 28.

引用本文的文献

1
Opportunities and challenges with artificial intelligence in allergy and immunology: a bibliometric study.人工智能在过敏与免疫学领域的机遇与挑战:一项文献计量学研究
Front Med (Lausanne). 2025 Apr 9;12:1523902. doi: 10.3389/fmed.2025.1523902. eCollection 2025.
2
The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment.缺失的酶:呼吁更新药理学分析方法以进行更好的药物安全性评估。
J Med Chem. 2025 Apr 24;68(8):7854-7865. doi: 10.1021/acs.jmedchem.4c02228. Epub 2025 Apr 2.
3
Exploring chemical space for "druglike" small molecules in the age of AI.

本文引用的文献

1
GeneWalk identifies relevant gene functions for a biological context using network representation learning.GeneWalk 使用网络表示学习来确定生物背景下相关的基因功能。
Genome Biol. 2021 Feb 2;22(1):55. doi: 10.1186/s13059-021-02264-8.
2
Deep learning-based cross-classifications reveal conserved spatial behaviors within tumor histological images.基于深度学习的跨分类揭示了肿瘤组织学图像中保守的空间行为。
Nat Commun. 2020 Dec 11;11(1):6367. doi: 10.1038/s41467-020-20030-5.
3
Systematic Chemogenetic Library Assembly.系统化学遗传学文库构建。
在人工智能时代探索“类药物”小分子的化学空间。
Front Mol Biosci. 2025 Mar 17;12:1553667. doi: 10.3389/fmolb.2025.1553667. eCollection 2025.
4
Applications of Artificial Intelligence in Drug Repurposing.人工智能在药物重新定位中的应用。
Adv Sci (Weinh). 2025 Apr;12(14):e2411325. doi: 10.1002/advs.202411325. Epub 2025 Mar 6.
5
Clinical Pharmacology of Asciminib: A Review.ASCIMINIB 的临床药理学:综述。
Clin Pharmacokinet. 2024 Nov;63(11):1513-1528. doi: 10.1007/s40262-024-01428-6. Epub 2024 Oct 29.
6
off-target profiling for enhanced drug safety assessment.用于增强药物安全性评估的脱靶分析
Acta Pharm Sin B. 2024 Jul;14(7):2927-2941. doi: 10.1016/j.apsb.2024.03.002. Epub 2024 Mar 6.
7
Machine Learning Techniques for Predicting Drug-Related Side Effects: A Scoping Review.用于预测药物相关副作用的机器学习技术:一项范围综述
Pharmaceuticals (Basel). 2024 Jun 17;17(6):795. doi: 10.3390/ph17060795.
8
Predicting therapeutic and side effects from drug binding affinities to human proteome structures.从药物与人蛋白质组结构的结合亲和力预测治疗效果和副作用。
iScience. 2024 May 20;27(6):110032. doi: 10.1016/j.isci.2024.110032. eCollection 2024 Jun 21.
9
DOCK-PET: database of CNS kinetic parameters in the healthy human brain for existing PET tracers.DOCK-PET:健康人脑内现有 PET 示踪剂的中枢神经系统动力学参数数据库。
Ann Nucl Med. 2024 Aug;38(8):666-672. doi: 10.1007/s12149-024-01947-z. Epub 2024 May 30.
10
The state of the art in secondary pharmacology and its impact on the safety of new medicines.二次药理学的最新进展及其对新药安全性的影响。
Nat Rev Drug Discov. 2024 Jul;23(7):525-545. doi: 10.1038/s41573-024-00942-3. Epub 2024 May 21.
Cell Chem Biol. 2020 Sep 17;27(9):1124-1129. doi: 10.1016/j.chembiol.2020.07.004. Epub 2020 Jul 23.
4
: Distributed Representations of Adverse Event Reporting System Data as a Means to Identify Drug/Side-Effect Associations.不良事件报告系统数据的分布式表示作为识别药物/副作用关联的一种手段
AMIA Annu Symp Proc. 2020 Mar 4;2019:717-726. eCollection 2019.
5
A Deep Learning Approach to Antibiotic Discovery.深度学习在抗生素发现中的应用。
Cell. 2020 Feb 20;180(4):688-702.e13. doi: 10.1016/j.cell.2020.01.021.
6
ModEx: A text mining system for extracting mode of regulation of transcription factor-gene regulatory interaction.ModEx:一种用于提取转录因子-基因调控相互作用的调控模式的文本挖掘系统。
J Biomed Inform. 2020 Feb;102:103353. doi: 10.1016/j.jbi.2019.103353. Epub 2019 Dec 16.
7
Artificial Intelligence for Drug Toxicity and Safety.人工智能在药物毒性和安全性方面的应用。
Trends Pharmacol Sci. 2019 Sep;40(9):624-635. doi: 10.1016/j.tips.2019.07.005. Epub 2019 Aug 2.
8
Chemi-Net: A Molecular Graph Convolutional Network for Accurate Drug Property Prediction.Chemi-Net:用于准确药物性质预测的分子图卷积网络。
Int J Mol Sci. 2019 Jul 10;20(14):3389. doi: 10.3390/ijms20143389.
9
Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects.与药物靶点编码基因相关的表型可预测临床试验的副作用。
Nat Commun. 2019 Apr 5;10(1):1579. doi: 10.1038/s41467-019-09407-3.
10
ADReCS-Target: target profiles for aiding drug safety research and application.ADReCS-Target:辅助药物安全研究和应用的目标特征。
Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.